In honor of “Medical Laboratory Professionals Week” (April 24-30), we at the University of Wisconsin–Madison Clinical Research Office would like to express our gratitude to all of the lab professionals in our clinical research community!...
Early clinical trials suggest vaccines that activate T cells work better and faster and may protect people with weakened immune systems....
Through the support of renowned alum Leon Lachman, the Institute harnesses expertise and enhances collaboration to move pharmaceutical therapies from the lab into the clinic....
What can we expect to see from decentralized trials in the next three years, and what are the challenges sponsor companies will need to overcome?...
We must apply lessons learned in the development of the COVID-19 vaccines, including community engagement strategies and innovative clinical trial design, to longstanding public health challenges such as TB....
Precision medicine, cell and gene therapies, decentralized trials, real-world data, and the promise of artificial intelligence and machine learning are just a few of the reasons to be excited about the future of clinical research....
The US Food and Drug Administration (FDA) is recommending sponsors include a plan to increase diversity when proposing clinical trial designs for investigational products to agency reviewers....
Some shared observations and recommendations highlighting examples that may bring decentralized and hybrid trials to a more tangible and realistic view and make them more executable....
A new clinical trial led by researchers at the University of Wisconsin-Madison could increase access to eye screenings for patients in rural Wisconsin....
UW Health received a top score of 100 in the "Health Equality Index, the nation’s foremost benchmarking survey of healthcare facilities on policies and practices dedicated to the equitable treatment and inclusion of their LGBTQ+ patients, visitors and employees....
